Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-31

Clinical Trial Update: Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features [Phase 4]

View source ↗

Summary

Phase 4 trial comparing olanzapine+lithium versus chlorpromazine+lithium for first manic episode with psychotic features in bipolar/schizoaffective disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorpromazine (chlorpromazine)
  • Lithium (Lithium carbonate)
  • olanzapine (olanzapine)

Snippet

Sponsor: Melbourne Health | Conditions: Bipolar Disorder, Schizoaffective Disorder | Phase 4 | Status: COMPLETED